Riskpilot← Back to searchSign inGet full accessZimmer Biomet Denmark ApS
APSActiveCVR 33051441Arne Jacobsens Allé 15Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201031 employees
Revenue 2024
DKK 59,7M
0% vs 2023
EBITDA margin
28.0%
+3% vs 2023
Equity ratio
76.6%
Financial strength
Net profit 2024
DKK 16,3M
+6% vs 2023
| Revenue | DKK 59,7M | +0% |
| EBITDA | DKK 16,7M | +3% |
| Net profit | DKK 16,3M | +6% |
| Total assets | DKK 141,8M | +5% |
| Equity | DKK 108,7M | +18% |
| Employees | 31 | — |
Legal name
Zimmer Biomet Denmark ApS
CVR number
33051441
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 2010
Share capital
DKK 983.128
Employees
31 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion
Company purpose
Selskabets formål er forskning, udvikling, produktion og handel med hensyn til medicinske implantater, tilhørende instrumenter og andet medicinsk udstyr og yde respektive tjenester. Selskabet kan påtage sig, udføre og udøve alle andre ting i tilknytning til opfyldelsen af disse formål.
Address
Arne Jacobsens Allé 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81.533 | 16.105 | 19.355 | 21.254 | 31.417 | 32.828 | 34.376 | 45.242 | 45.797 | 45.758 | 53.099 | 59.572 | 59.669 |
| Staff expenses | -8.350 | -9.709 | -12.452 | -14.022 | -28.888 | -26.584 | -26.879 | -29.093 | -34.082 | -35.631 | -37.858 | -43.284 | -42.934 |
| EBITDA | 6.836 | 6.396 | 6.903 | 7.232 | 2.529 | 6.244 | 7.496 | 16.150 | 11.715 | 10.127 | 15.241 | 16.288 | 16.735 |
| Depreciation & amort. | -4.405 | -4.482 | -4.339 | -4.241 | -2.002 | -157 | -87 | -90 | -72 | -31 | -10 | -10 | -7 |
| EBIT | 2.431 | 1.914 | 2.564 | 2.991 | 527 | 6.087 | 7.410 | 16.059 | 11.643 | 10.096 | 15.231 | 16.278 | 16.728 |
| Net financials | 13 | 6 | -21 | -9 | 4 | 1.097 | -182 | -305 | -276 | -346 | -376 | 3.524 | 4.335 |
| Profit before tax | 2.444 | 1.920 | 2.543 | 2.981 | 530 | 7.184 | 7.228 | 15.754 | 11.367 | 9.750 | 14.855 | 19.801 | 21.063 |
| Tax | 643 | 583 | 707 | 818 | 472 | 1.729 | 1.712 | 3.538 | 2.646 | 2.165 | 3.379 | 4.424 | 4.796 |
| Net profit | 1.801 | 1.337 | 1.836 | 2.163 | 58 | 5.455 | 5.515 | 12.216 | 8.721 | 7.584 | 11.476 | 15.378 | 16.267 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 42.292 | 28.181 | 28.459 | 30.486 | 94.306 | 118.806 | 67.918 | 77.144 | 86.384 | 91.705 | 116.261 | 134.869 | 141.820 |
| Equity | 3.223 | 4.560 | 4.397 | 5.560 | 74.331 | 81.955 | 42.020 | 49.236 | 57.957 | 65.542 | 77.018 | 92.396 | 108.663 |
| Long-term debt | 9.441 | 0 | 0 | 0 | 0 | -802 | -601 | 865 | 2.782 | 0 | -252 | -200 | -150 |
| Short-term debt | 29.627 | 23.620 | 24.062 | 24.926 | 16.375 | 34.213 | 25.898 | 27.043 | 25.645 | 26.164 | 39.244 | 42.473 | 33.157 |
| Total debt | 39.068 | 23.620 | 24.062 | 24.926 | 16.375 | 34.213 | 25.898 | 27.907 | 28.427 | 26.164 | 39.244 | 42.473 | 33.157 |
EBITDA margin
28.0%
This company
15.8%
Market median
+77% vs market
20122024
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20122024
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20122024
Net profit margin
27.3%
This company
8.1%
Market median
+237% vs market
20122024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20122024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MP Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
CS Management | Management | 2010 | — | — |
AM Management | Management | 2019 | — | — |
LJ Management | Management | 2010 | — | — |
SO Management | Management | 2017 | — | — |
HG Management | Management | 2010 | — | — |
AM Management | Management | 2010 | — | — |
BV Management | Management | 2024 | — | — |
CJ Management | Management | 2010 | — | — |
AL Management | Management | 2025 | — | — |
KM Management | Management | 2022 | — | — |
CL Management | Management | 2025 | — | — |
JL Management | Management | 2022 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2018 | |
| Individual | 100.0% | 100.0% | 2015 | |
| Individual | 100.0% | 100.0% | 2010 | |
| Individual | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zimmer Biomet Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Persson | Chief Executive Officer | 0 companies |
| Caroline Sundorph Pontoppidan | Management | 0 companies |
| Alan Michael Green | Management | 0 companies |
| Lars Joakim Rang | Management | 0 companies |
| Steven Orange | Management | 0 companies |
| Hans Gustav Teslow Naess | Management | 0 companies |
| Antony Massarella | Management | 0 companies |
| Bo Vendelboe | Management | 0 companies |
| Christopher John Jefferis | Management | 0 companies |
| Alan Lentz Wiese | Management | 0 companies |
| Koen Marleen Clerinx | Management | 0 companies |
| Claire Lisa Savine | Management | 0 companies |
| Jennie Linn Alecia Christensson | Management | 0 companies |
| Jenny Madelene Stokke | Chief Executive Officer | 0 companies |